These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
625 related articles for article (PubMed ID: 15382196)
21. Evaluation of clinico-urodynamic outcome of bladder dysfunction after surgery in children with spinal dysraphism - a prospective study. Kumar R; Singhal N; Gupta M; Kapoor R; Mahapatra AK Acta Neurochir (Wien); 2008 Feb; 150(2):129-37. PubMed ID: 18213439 [TBL] [Abstract][Full Text] [Related]
22. Outcome in patients who underwent tethered cord release for occult spinal dysraphism. Guerra LA; Pike J; Milks J; Barrowman N; Leonard M J Urol; 2006 Oct; 176(4 Pt 2):1729-32. PubMed ID: 16945634 [TBL] [Abstract][Full Text] [Related]
23. Oral nitric oxide donors: a new pharmacological approach to detrusor-sphincter dyssynergia in spinal cord injured patients? Reitz A; Knapp PA; Müntener M; Schurch B Eur Urol; 2004 Apr; 45(4):516-20. PubMed ID: 15041118 [TBL] [Abstract][Full Text] [Related]
24. The lazy bladder syndrome: a possible urodynamic evolution in patients with idiopatic detrusor and pelvic floor overactivity. Merlini E; Sangiorgio L; Seymandi P Pediatr Med Chir; 2004; 26(3):187-90. PubMed ID: 16366402 [TBL] [Abstract][Full Text] [Related]
25. Structural basis of neurogenic bladder dysfunction. II. Myogenic basis of detrusor hyperreflexia. Haferkamp A; Dörsam J; Resnick NM; Yalla SV; Elbadawi A J Urol; 2003 Feb; 169(2):547-54. PubMed ID: 12544305 [TBL] [Abstract][Full Text] [Related]
26. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859 [TBL] [Abstract][Full Text] [Related]
27. Voiding dysfunction after radical retropubic prostatectomy: more than external urethral sphincter deficiency. Porena M; Mearini E; Mearini L; Vianello A; Giannantoni A Eur Urol; 2007 Jul; 52(1):38-45. PubMed ID: 17403565 [TBL] [Abstract][Full Text] [Related]
28. Role of gabapentin and anticholinergics in management of neurogenic bladder after repair of spina bifida - a randomized controlled study. Dash V; Bawa M; Mahajan JK; Kanojia RP; Samujh R; Rao KL J Pediatr Surg; 2016 Dec; 51(12):2025-2029. PubMed ID: 27680597 [TBL] [Abstract][Full Text] [Related]
30. Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida. Ferrara P; D'Aleo CM; Tarquini E; Salvatore S; Salvaggio E BJU Int; 2001 May; 87(7):674-8. PubMed ID: 11350411 [TBL] [Abstract][Full Text] [Related]
31. Natural fill urodynamics and conventional cystometrogram in infants with neurogenic bladder. Jorgensen B; Olsen LH; Jorgensen TM J Urol; 2009 Apr; 181(4):1862-7; discussion 1867-8. PubMed ID: 19233391 [TBL] [Abstract][Full Text] [Related]
32. Efficacy, tolerability, and safety of oxybutynin chloride in pediatric neurogenic bladder with spinal dysraphism: a retrospective, multicenter, observational study. Lee JH; Kim KR; Lee YS; Han SW; Kim KS; Song SH; Baek M; Park K Korean J Urol; 2014 Dec; 55(12):828-33. PubMed ID: 25512818 [TBL] [Abstract][Full Text] [Related]
33. Early start to therapy preserves kidney function in spina bifida patients. Dik P; Klijn AJ; van Gool JD; de Jong-de Vos van Steenwijk CC; de Jong TP Eur Urol; 2006 May; 49(5):908-13. PubMed ID: 16458416 [TBL] [Abstract][Full Text] [Related]
34. Treatment with modified intravesical oxybutynin chloride for neurogenic bladder in children. Hayashi A; Saito M; Okada S; Hanada T; Watanabe T; Satoh K; Kanzaki S J Pediatr Urol; 2007 Dec; 3(6):438-42. PubMed ID: 18947791 [TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Gamé X; Castel-Lacanal E; Bentaleb Y; Thiry-Escudié I; De Boissezon X; Malavaud B; Marque P; Rischmann P Eur Urol; 2008 Mar; 53(3):613-8. PubMed ID: 17804150 [TBL] [Abstract][Full Text] [Related]
36. The management of paediatric neurogenic bladder: an approach in a resource-poor setting. Maison POM; Lazarus J Paediatr Int Child Health; 2017 Nov; 37(4):280-285. PubMed ID: 28714784 [TBL] [Abstract][Full Text] [Related]
37. [Use of oral anticholinergic therapy in children under 1 years of age with high risk bladder]. Luque Mialdea R; Martín-Crespo R; Hernández E; Sánchez O; Cañizo A; Fernández A; Aparicio C; Blanco T; Cebrían J Cir Pediatr; 2005 Jan; 18(1):3-7. PubMed ID: 15901100 [TBL] [Abstract][Full Text] [Related]
38. The effects of bladder neck incision on urodynamic abnormalities of children with posterior urethral valves. Kajbafzadeh AM; Payabvash S; Karimian G J Urol; 2007 Nov; 178(5):2142-7; discussion 2147-9. PubMed ID: 17870121 [TBL] [Abstract][Full Text] [Related]
39. Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity? Kessler TM; Danuser H; Schumacher M; Studer UE; Burkhard FC Neurourol Urodyn; 2005; 24(3):231-6. PubMed ID: 15747344 [TBL] [Abstract][Full Text] [Related]
40. Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity. Reitz A; Denys P; Fermanian C; Schurch B; Comperat E; Chartier-Kastler E Eur Urol; 2007 Dec; 52(6):1729-35. PubMed ID: 17884281 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]